Patents by Inventor Yali Cui
Yali Cui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11938653Abstract: The present invention relates to a powder dry-pressing molding device and method.Type: GrantFiled: May 8, 2020Date of Patent: March 26, 2024Assignees: QINGDAO UNIVERSITY OF TECHNOLOGY, SHENYANG HONGYANG PRECISION CERAMICS CO., LTD.Inventors: Changhe Li, Mingcun Shi, Xiangyang Ma, Baoda Xing, Xiaohong Ma, Yanbin Zhang, Min Yang, Xin Cui, Teng Gao, Xiaoming Wang, Yali Hou, Han Zhai, Zhen Wang, Bingheng Lu, Huajun Cao, Naiqing Zhang, Qidong Wu
-
Publication number: 20240096428Abstract: A memory device includes a first deck including a first set of word lines, a second deck including a second set of word lines, and a controller. The controller is configured to apply a program voltage to a first word line of the first set of word lines, apply a first pass voltage to a second word line of the second set of word lines while applying the program voltage to the first word line, and apply a second pass voltage to a third word line of the first set of word lines while applying the program voltage to the first word line. The third word line is between the first word line and the second word line. The second pass voltage is greater than the first pass voltage.Type: ApplicationFiled: November 24, 2023Publication date: March 21, 2024Inventors: Yali SONG, XiangNan Zhao, Ying Cui
-
Patent number: 11697658Abstract: The present disclosure relates to the technical field of drug synthesis, in particular to a method for preparing lornoxicam. The method includes the following steps: using 6-chloro-4-hydroxy-2-methyl-2-H-thieno[2,3-e]-1,2-thiazine methyl carboxylate-1,1-dioxide and 2-aminopyridine as raw materials, and xylene as a solvent; mixing the raw material and solvent, and adding a stabilizer, to obtain a mixture; subjecting the mixture to an ammonolysis; cooling the resulting reactant; conducting a vacuum concentration to remove the solvent; adding an organic solvent and slurrying, and filtering, to obtain a crude lornoxicam; and refining the crude lornoxicam to obtain the lornoxicam. In the present disclosure, p-toluenesulfonic acid is used as a stabilizer to reduce the reaction temperature and promote the reaction to proceed forward, thereby improving the quality and yield of the product.Type: GrantFiled: July 23, 2021Date of Patent: July 11, 2023Assignee: Beijing Jincheng Taier Pharmaceutical Co., Ltd.Inventors: Zhen Liu, Dongye Xing, Zhongzheng Zhang, Jie Li, Yangong Han, Yali Cui, Liru Wang, Hongliang Liu, Yan Mi, Li Li, Jingang Tang, Yi Kang
-
Publication number: 20220204529Abstract: The present disclosure relates to the technical field of drug synthesis, in particular to a method for preparing lornoxicam. The method includes the following steps: using 6-chloro-4-hydroxy-2-methyl-2-H-thieno[2,3-e]-1,2-thiazine methyl carboxylate-1,1-dioxide and 2-aminopyridine as raw materials, and xylene as a solvent; mixing the raw material and solvent, and adding a stabilizer, to obtain a mixture; subjecting the mixture to an ammonolysis; cooling the resulting reactant; conducting a vacuum concentration to remove the solvent; adding an organic solvent and slurrying, and filtering, to obtain a crude lornoxicam; and refining the crude lornoxicam to obtain the lornoxicam. In the present disclosure, p-toluenesulfonic acid is used as a stabilizer to reduce the reaction temperature and promote the reaction to proceed forward, thereby improving the quality and yield of the product.Type: ApplicationFiled: July 23, 2021Publication date: June 30, 2022Inventors: Zhen LIU, Dongye XING, Zhongzheng ZHANG, Jie LI, Yangong HAN, Yali CUI, Liru WANG, Hongliang LIU, Yan MI, Li LI, Jingang TANG, Yi KANG
-
Patent number: 8501459Abstract: High-throughput detection for the interesting base or the mutation site in the nucleic acid sample can be achieved by means of the linear test probe pairs P1 and P2. The test probe pairs P1 and P2 respectively comprise either of the flanking complementary sequences which are adjacent to the interesting base or the mutation site in the nucleic acid sample. The invention can be applied to the re-sequencing the target nucleic acid sequence, the detection and analysis for the mutation, insertion, or deletion sites of a known nucleic acid sequence, and the genotyping of the pathogenic microorganism.Type: GrantFiled: October 6, 2008Date of Patent: August 6, 2013Assignee: Shaan Xi Lifegen Co., Ltd.Inventors: Chao Chen, Yitong Tang, Yali Cui, Juanli Zhu, Longlin Yu, Yiwen Gao, Zheng Li
-
Patent number: 8409544Abstract: Disclosed is a process of preparing magnetite nanoparticles, comprising the following steps: 1) preparing a ferric salt mixed system, wherein a soluble ferric salt is dissolved in glycol at ambient temperature, and then urea and polyethylene glycol are added and mixed homogeneously to obtain the trivalent iron salt mixed system, the mass ratio of glycol to the trivalent iron salt being 15:1 to 60:1, glycol to urea being 20:1 to 100:1, and glycol to polyethylene glycol being 20:1 to 100:1; 2) reacting, wherein the trivalent iron salt mixed system is transferred into a reaction autoclave, sealed and placed into a heating device to react at a temperature of 200 to 300° C. for 8 to 72 hours; and 3) washing, wherein after the reaction system is naturally cooled down to ambient temperature, the product is taken out, and washed with anhydrous ethanol and water in turn to obtain the magnetite nanoparticles. The soluble iron salt includes ferric chloride, ferric sulfate, ferric acetate and ferric nitrate.Type: GrantFiled: December 31, 2008Date of Patent: April 2, 2013Assignee: Xi'an Goldmag Nanobiotech Co. Ltd.Inventors: Mingli Peng, Caiquan Zhang, Yali Cui, Chao Chen, Jinghui Zeng
-
Publication number: 20120121717Abstract: The invention relates to Polysaccharide-coated GoldMag particles (DPGPs) and the method of its synthesis, which characterized GoldMag particles as a core and natural or synthetic biodegradable polysaccharide such as dextran, cyclodextrin and derivatives as shell. DPGPs are synthesized by mixing Polysaccharide-coated GoldMag particles (DPGPs) with drug through physical bond. The preparation of the drug-loaded composite particles include: preparing the polysaccharide-coated GoldMag particles and then loading the drug on the polysaccharide-coated GoldMag particles. The drug-loading process is carried out through directly mixing the polysaccharide-coated GoldMag particles with the drug solution by the shaker. That means the polysaccharide-coated GoldMag particles load the drug through affinity adsorption.Type: ApplicationFiled: December 30, 2008Publication date: May 17, 2012Inventors: Xu Chao, Yali Cui, Mingli Peng, Chao Chen, Xiaofang Xin, Ke Li, Wenli Hui
-
Publication number: 20120003321Abstract: The present invention relates to crosslinked dextran magnetic composite microparticles and a preparation process and a using method thereof. The composite microparticles comprise magnetic nanoparticles and dextran with crosslinked structure, wherein the magnetic nanoparticles are dispersed in the dextran with crosslinked structure. The process for preparing the composite microparticles comprises: preparing a dextran solution; synthesizing dextran magnetic composite microparticles; and synthesizing the crosslinked dextran magnetic composite microparticles. The using method of composite microparticles comprises: preparing crosslinked dextran magnetic composite microparticles loaded with anti-cancer drug; and adding a sustained-releasing solution thereto.Type: ApplicationFiled: December 29, 2008Publication date: January 5, 2012Applicant: XI'AN GOLDMAG NANOBIOTECH CO. LTD.Inventors: Mingli Peng, Yanhong Liu, Yali Cui, Chao Chen, Ke Li
-
Publication number: 20110318261Abstract: Disclosed is a process of preparing magnetite nanoparticles, comprising the following steps: 1) preparing a ferric salt mixed system, wherein a soluble ferric salt is dissolved in glycol at ambient temperature, and then urea and polyethylene glycol are added and mixed homogeneously to obtain the trivalent iron salt mixed system, the mass ratio of glycol to the trivalent iron salt being 15:1 to 60:1, glycol to urea being 20:1 to 100:1, and glycol to polyethylene glycol being 20:1 to 100:1; 2) reacting, wherein the trivalent iron salt mixed system is transferred into a reaction autoclave, sealed and placed into a heating device to react at a temperature of 200 to 300° C. for 8 to 72 hours; and 3) washing, wherein after the reaction system is naturally cooled down to ambient temperature, the product is taken out, and washed with anhydrous ethanol and water in turn to obtain the magnetite nanoparticles. The soluble iron salt includes ferric chloride, ferric sulfate, ferric acetate and ferric nitrate.Type: ApplicationFiled: December 31, 2008Publication date: December 29, 2011Applicant: XI'AN GOLDMAG NANOBIOTECH CO. LTD.Inventors: Mingli Peng, Caiquan Zhang, Yali Cui, Chao Chen, Jinghui Zeng
-
Publication number: 20110218115Abstract: High-throughput detection for the interesting base or the mutation site in the nucleic acid sample can be achieved by the linear test probe pairs P1 and P2. The test probe pairs P1 and P2 respectively comprise either of the flanking complementary sequences which are adjacent to the interesting base or the mutation site in the nucleic acid sample. When the test probe pairs P1, P2 are annealed and hybridized to the nucleic acid sample, a gap will be generated at the interesting base or the mutation site position between the probe pairs and the sample. Divide the annealed hybrid sample into four equal reaction systems to which add dATP, dTTP, dCTP, dGTP, respectively. The test probe pairs P1 and P2 will be ligated into one single probe when adding the complementary nucleotide system under the DNA polymerase or ligase. After purified and amplified, the generated single probes are hybridized to the corresponding area in a common oligonucleotide microarray.Type: ApplicationFiled: October 6, 2008Publication date: September 8, 2011Applicant: SHAAN XI LIFEGEN CO., LTD.Inventors: Chao Chen, Yitong Tang, Yali Cui, Juanli Zhu, Longlin Yu, Yiwen Gao, Zheng Li
-
Patent number: 7175912Abstract: The invention relates to a super-paramagnetic composite particle with core/shell structure, preparation method and use thereof. The composite particle is consisted of a core portion and a shell portion coated on the surface of the core portion, wherein said core portion is 10–70% by weight and said shell portion is 30–90% by weight based on the total weight of the composite particle, and said core portion is consisted of magnetic particles of Fe3O4, ?-Fe2O3 or other ferric oxides, or magnetic particles of ferrites of tervalent ferrum and bivalent manganese, nickel, zinc or copper, and the said shell portion is consisted of elementary gold or silver. The particle has an average diameter of 0.05–50 ?m. The preparation method comprises preparing the core portion magnetic particle by chemical co-precipitation and depositing gold or silver to coat the magnetic particle by chemical reduction.Type: GrantFiled: April 28, 2004Date of Patent: February 13, 2007Assignee: Shanxi Lifegen Co., Ltd.Inventors: Yali Cui, Chao Chen, Qiong Wang, Wenli Hui
-
Publication number: 20040219361Abstract: The invention relates to a super-paramagnetic composite particle with core/shell structure, preparation method and use thereof. The composite particle is consisted of a core portion and a shell portion coated on the surface of the core portion, wherein said core portion is 10-70% by weight and said shell portion is 30-90% by weight based on the total weight of the composite particle, and said core portion is consisted of magnetic particles of Fe3O4, &ggr;-Fe2O3 or other ferric oxides, or magnetic particles of ferrites of tervalent ferrum and bivalent manganese, nickel, zinc or copper, and the said shell portion is consisted of elementary gold or silver. The particle has an average diameter of 0.05-50 &mgr;m. The preparation method comprises preparing the core portion magnetic particle by chemical co-precipitation and depositing gold or silver to coat the magnetic particle by chemical reduction.Type: ApplicationFiled: April 28, 2004Publication date: November 4, 2004Applicant: Shanxi Lifegen Co., Ltd.Inventors: Yali Cui, Chao Chen, Qiong Wang, Wenli Hui